← Eichor
Study identifier: NCT06717958 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation

Condition: AML · MDS  ·  Sponsor: Technische Universität Dresden

PhasePhase 2
Planned participants76
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

maintenance of AML or MDS patients with known IDH1 mutation after allogeneic stem cell transplantation within past 100 days

This description comes directly from the study's public registry record.

Talk to the study team

Jan Moritz Middeke, Dr. med.  ·  +493514583192  ·  pivot@ukdd.de

Friedrich Stölzel, Prof. Dr. med.  ·  +493514583192  ·  pivot@ukdd.de

Always discuss trial participation with your own doctor first.

Locations (12)

Universitätsklinikum AachenAachen, GermanyNot Yet Recruiting
Technische Universitaet Dresden, Medizinische Klinik und Poliklinik IDresden, GermanyNot Yet Recruiting
Universitätsklinikum EssenEssen, GermanyNot Yet Recruiting
Martin-Luther-Universitaet Halle-WittenbergHalle, GermanyRecruiting
University Medical Center Hamburg-EppendorfHamburg, GermanyNot Yet Recruiting
Universitätsklinikum JenaJena, GermanyNot Yet Recruiting
Universitätsklinikum Schleswig-HolsteinKiel, GermanyRecruiting
Universität LeipzigLeipzig, GermanyNot Yet Recruiting
Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)München, GermanyNot Yet Recruiting
Universität MünsterMünster, GermanyNot Yet Recruiting
Rostock University Medical CenterRostock, GermanyNot Yet Recruiting
Universitaetsklinikum UlmUlm, GermanyNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06717958